Given the important role of inflammation in atherosclerosis, the present study aimed to investigate 1) whether functionally active VAP-1 is expressed in atherosclerotic plaques, and 2) whether the new VAP-1-targeting radioligand [68Ga]DOTA-Siglec-9 can detect inflamed atherosclerotic lesions. Here, AOC3 is linked to atherosclerosis.